A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer-Reference-Cited by-同舟云学术

A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer

Published:2016-05-23 Issue:7 Volume:22 Page:744-753
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Dauch Daniel,Rudalska Ramona,Cossa Giacomo,Nault Jean-Charles,Kang Tae-Won,Wuestefeld Torsten,Hohmeyer Anja,Imbeaud Sandrine,Yevsa Tetyana,Hoenicke Lisa,Pantsar Tatu,Bozko Przemyslaw,Malek Nisar P,Longerich Thomas,Laufer Stefan,Poso Antti,Zucman-Rossi Jessica^ORCID,Eilers Martin^ORCID,Zender Lars

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4107.pdf

Reference60 articles.

1. Eilers, M. & Eisenman, R.N. Myc's broad reach. Genes Dev. 22, 2755–2766 (2008).

2. Meyer, N. & Penn, L.Z. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976–990 (2008).

3. Soucek, L. et al. Modeling Myc inhibition as a cancer therapy. Nature 455, 679–683 (2008).

4. Shachaf, C.M. et al. MYC inactivation uncovers pluripotent differentiation and tumor dormancy in hepatocellular cancer. Nature 431, 1112–1117 (2004).

5. Felsher, D.W. & Bishop, J.M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199–207 (1999).

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Essential roles of B-cell subsets in the progression of MASLD and HCC;JHEP Reports;2024-08

2. Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma;Cells;2024-07-06

3. Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer;Nature Reviews Clinical Oncology;2024-07-04

4. SOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation;Cancer Letters;2024-07

5. Defeating MYC with drug combinations or dual-targeting drugs;Trends in Pharmacological Sciences;2024-06